MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: Exploration of aromatic substituents-Reference-Cited by-同舟云学术

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: Exploration of aromatic substituents

Published:2006-12 Issue:24 Volume:14 Page:8506-8518
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Yoshida Ken-ichi,Nakayama Kiyoshi,Yokomizo Yoshihiro,Ohtsuka Masami,Takemura Makoto,Hoshino Kazuki,Kanda Hiroko,Namba Kenji,Nitanai Hironobu,Zhang Jason Z.,Lee Ving J.,Watkins William J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference13 articles.

1. Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa

2. Efflux-mediated antimicrobial resistance

3. Bacterial resistance to antibiotics: Active efflux and reduced uptake

4. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon

5. MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2,2‐Difluoroethylation of Heteroatom Nucleophiles via a Hypervalent Iodine Strategy;Angewandte Chemie International Edition;2024-08-08

2. 2,2‐Difluoroethylation of Heteroatom Nucleophiles via a Hypervalent Iodine Strategy;Angewandte Chemie;2024-08-08

3. Machine Learning-Guided Discovery of AcrB and MexB Efflux Pump Inhibitors;The Journal of Physical Chemistry B;2024-01-10

4. Exploring transmembrane allostery in the MexB: DB08385 variant as a promising inhibitor-like candidate against Pseudomonas aeruginosa antibiotic resistance: a computational study;Physical Chemistry Chemical Physics;2024

5. Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular dynamics approaches;Molecular Diversity;2023-11-03